← Browse by Condition
Medical Condition

cerebrovascular disease

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for cerebrovascular disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cerebrovascular disease Clinical Trials

How many clinical trials are currently recruiting for cerebrovascular disease?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for cerebrovascular disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cerebrovascular disease?
cerebrovascular disease research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cerebrovascular disease clinical trial?
Eligibility criteria for cerebrovascular disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
Shanghai 6th People's Hospital 1 trial
Children's Hospital of Fudan University 1 trial
Hanyang University Guri Hospital 1 trial

Recruiting Clinical Trials

NCT06241482
Recruiting
Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care
Enrollment
80 pts
Location
China
Sponsor
Shanghai 6th People's Hospital
View Trial →
NCT06668519
Recruiting
Magnetoencephalography in Children
Enrollment
1,500 pts
Location
China
Sponsor
Children's Hospital of Fudan U...
View Trial →
NCT07687706 Phase 3
Recruiting
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
Enrollment
1,524 pts
Location
South Korea
Sponsor
Hanyang University Guri Hospit...
View Trial →

Related Conditions

neurocritical care (1) traumatic brain injury (1) moderate or severe coma (1) epilepsy (1) intracranial tumors (1) autism (1) adhd attention deficit disorder with hyperactivity (1) neuropsychiatric disorders (1) tic disorder childhood (1) mental retardation (1) developmental disabilities (1) ischemic stroke (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology